nimacimab glp-1 news Skye Bioscience's Nimacimab: A Transformative Approach to Obesity with Multi-Faceted Potential Skye Bioscience, Inc. (SKYE) Securities
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28























